CN Stock MarketDetailed Quotes

002437 Harbin Gloria Pharmaceuticals

Watchlist
  • 2.44
  • +0.05+2.09%
Market Closed Jan 6 15:00 CST
5.56BMarket Cap69.71P/E (TTM)

Harbin Gloria Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Harbin Gloria Pharmaceuticals Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
636.20M
--
+2.72%
EPS
--
0.03
--
--
Analyst Rating
No Data

Harbin Gloria Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.529B--
--2024/FY-- / 2.331B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.529B--
--2024/FY-- / 2.331B--
--------
--------
--------

Unlock Free Earnings Estimates

Harbin Gloria Pharmaceuticals Earnings Reports

  • Yuheng Pharmaceutical: Report for the third quarter of 2024

    Oct 28, 2024 12:00 ET

  • Harbin Gloria Pharmaceuticals: Half-year report for the year 2024.

    Aug 23, 2024 12:00 ET

  • Harbin Gloria Pharmaceuticals: Summary of Half-Year Report in 2024.

    Aug 23, 2024 12:00 ET

  • Harbin Gloria Pharmaceuticals: 2024 Interim Performance Forecast

    Jul 2, 2024 12:00 ET

    • Read more

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Biomedical
    Biomedical
    Intraday+1.48%
    Gene Sequencing
    Gene Sequencing
    Intraday+1.27%
    Monoclonal Antibody Concept
    Monoclonal Antibody Concept
    Intraday+0.93%